Crescent Capital BDC, Inc. (CCAP) stock
Close on Nov 13, 2026Market cap $373.25MP/E 12.2Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $373.25M
- P/E ratio
- 12.2
- Price to sales
- –
- Price to book
- 0.57
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$156.00K
- EPS, diluted
- $0.83
- Book value per share
- $17.72
- Diluted shares
- 37M
Trading
- Next earnings
- Feb 24, 2027 (estimated, during market hours)
- Previous close
- $10.10
- Open
- $10.18
- Day's range
- $9.95 – $10.24
- Volume
- 214,593
- Average volume (20 days)
- 205,820
- Beta (5 years)
- 0.57
- 52-week range
- $8.39 – $15.18
- RSI (14 days)
- 63.3
- Volatility (1 year)
- 30.2%
- Relative volume
- 0.87×
- WACC
- 7.9%
On 1 of our idea list: Yields that look too good (a warning list)
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CCAP | S&P 500 | Difference | CCAP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.8% | -3.0% | +13.9 pts | ||
| 3 months | -7.0% | -2.8% | −4.2 pts | ||
| Year to date | -19.8% | +11.5% | −31.2 pts | ||
| 1 year | -14.6% | +13.5% | −28.0 pts | ||
| 3 years | -11.9% | +77.7% | −89.6 pts | -4.1% | +21.1% |
| 5 years | -11.7% | +72.6% | −84.3 pts | -2.4% | +11.5% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Press releases
Releases Crescent Capital BDC filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Crescent Capital BDC
The company is a specialty finance firm that operates as a business development company providing financing solutions to middle-market businesses. Its core offerings consist of secured debt instruments, including first-lien, unitranche, and second-lien loans, alongside unsecured debt such as mezzanine and subordinated facilities, and related equity investments. It supplies capital through directly originated private credit transactions as well as syndicated debt arrangements. These financing products support corporate initiatives including business expansion, acquisitions, refinancings, and private equity sponsor buyouts. The firm primarily serves private middle-market enterprises located in the United States across diverse industry sectors, focusing on businesses backed by private equity firms.
Company profile, executives and historyCrescent Capital BDC stock: common questions
What is Crescent Capital BDC's stock price?
CCAP closed at $10.13 on Nov 13, 2026, up 0.30% on the day. Over the past 52 weeks it traded between $8.39 and $15.18.
What is Crescent Capital BDC's market cap?
Crescent Capital BDC was worth $373.25M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is CCAP's P/E ratio?
CCAP trades at 12.2 times earnings, based on diluted earnings per share of $0.83 over the twelve months to Sep 30, 2026.
Does Crescent Capital BDC pay a dividend?
No. Crescent Capital BDC has not paid a cash dividend over the last twelve months.
When does Crescent Capital BDC report earnings next?
Crescent Capital BDC is expected to report Q4 FY2026 results on Feb 24, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has CCAP stock performed over the past year?
Including dividends, CCAP returned -14.6% over the past year, against +13.5% for the S&P 500.
How many CCAP shares are sold short?
1M shares were sold short at the latest FINRA report, 3.09% of the float, or 4.2 days of average trading volume.
See a number that looks wrong?